| DAUPHIN, Claire |
MYOCOVID, NCT04375748: Hospital Registry of Acute Myocarditis: Evolution of the Proportion of Positive SARS-COV-2 (COVID19) Cases |
|
|
| Completed | N/A | 756 | Europe, RoW | Performing routine care (clinical and paraclinical tests), Examinations for the research: | University Hospital, Toulouse | Acute Myocarditis | 12/21 | 12/21 | | |
| Completed | N/A | 203 | Europe | Oral anticoagulant treatment, warfarin (Coumadine®), fluindione (Préviscan®), acenocoumarol (Sintrom®) | Centre Hospitalier Universitaire de Saint Etienne | Pulmonary Arterial Hypertension | 09/22 | 09/23 | | |
PROOF, NCT04029233: The Trial - Prospective, Open-label, Multicenter, Non-randomized Investigation on Percutaneous Patent Foramen Ovale (PFO) Closure Using the Occlutech PFO Occluder to Prevent Recurrence of Stroke in Patients With Cryptogenic Stroke and High Risk PFO |
|
|
| Terminated | N/A | 582 | Europe, Canada | Occlutech PFO Occluder, Occlutech Figulla Flex II Occluder | Occlutech International AB | Stroke, PFO - Patent Foramen Ovale | 04/24 | 04/24 | | |
| Recruiting | N/A | 60 | Europe | OPTIMUS covered stent, Surgical correction of a SVD | Centre Chirurgical Marie Lannelongue | Sinus Venosus Defect, Congenital Heart Disease, Sinus Venosus Atrial Septum Defect | 05/24 | 05/29 | | |
| Completed | N/A | 49 | Europe | Rehabilitation, Supervised rehabilitation | Centre Hospitalier Universitaire de Saint Etienne, Ministry of Health, France | Pulmonary Arterial Hypertension | 12/22 | 01/24 | | |
| Active, not recruiting | N/A | 251 | Europe | Amplatzer™ Trevisio™ Intravascular Delivery System using Amplatzer PFO Occluder, ASO or Amplatzer Cribriform Occluder, Amplatzer™ Trevisio™ Intravascular Delivery System using Amplatzer Muscular VSD Occluder or Amplatzer Post-Infarct Muscular VSD Occluder | Abbott Medical Devices | PFO - Patent Foramen Ovale, ASD - Atrial Septal Defect, VSD - Muscular Ventricular Septal Defect, PIVSD - Post Infarct Muscular Ventricular Septal Defect | 09/25 | 10/25 | | |
